Fluor-Built Pharmaceutical Facility in California is First Industrial Manufacturing Facility in Western United States to Achieve LEED v4 Platinum Certification
Facility also named 2025 ISPE Facility of the Year Winner for Social Impact - Unmet Medical Needs
Bayer's Cell Therapy Launch Facility in
LEED v4 Platinum certification is the highest level of recognition for sustainable building practices and indicates that a building meets the highest standards for sustainability.
Fluor’s scope of work included the engineering, procurement, construction management, commissioning, qualification and validation for the 144,000-square-foot, state-of-the-art facility. It features 30,000 square feet of cleanroom space dedicated to advancing cell therapy production for neurological degenerative disorders, cardiovascular disease and other unmet medical needs.
"Fluor and Bayer collaborated to deliver Bayer's first fully electric pharmaceutical manufacturing plant, and we met an aggressive schedule to support client and patient needs," said Richard Meserole, President of Fluor’s Advanced Technologies & Life Sciences business. “Fluor secured LEED v4 Platinum Certification and ISPE Facility of the Year designation through effective collaboration with our trade partners, lean construction methods, and dedication to quality.”
Sustainability benefits for the facility include
This is the second new facility built by Fluor on Bayer’s Biotech campus in
About Fluor Corporation:
Fluor Corporation (NYSE: FLR) is building a better world by applying world-class expertise to solve its clients’ greatest challenges. Fluor’s nearly 27,000 employees provide professional and technical solutions that deliver safe, well-executed, capital-efficient projects to clients around the world. Fluor had revenue of
#atls
View source version on businesswire.com: https://www.businesswire.com/news/home/20250519864245/en/
Brett Turner
Media Relations
864.281.6976
Jason Landkamer
Investor Relations
469.398.7222
Source: Fluor Corporation
